Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth

Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth

Background: Since the early 2000s rituximab (RTX) has been thought of as an alternative treatment for steroid-sensitive nephrotic syndrome (SSNS) and steroid-resistant nephrotic syndrome (SRNS).Objective: This study aimed to determine the effects of RTX treatment on disease outcome and growth in ped...

Full description

Bibliographic Details
Main Authors: Rezan Topaloğlu, Bora Gülhan, Kübra Çelegen, Mihriban İnözü, Mutlu Hayran, Ali Düzova, Fatih Ozaltin
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Pediatrics
Subjects:
rituximab
nephrotic syndrome
steroid
cyclosporine
growth
Online Access:https://www.frontiersin.org/article/10.3389/fped.2019.00313/full

Internet

https://www.frontiersin.org/article/10.3389/fped.2019.00313/full

Similar Items